{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:21:44Z","timestamp":1791235304167,"version":"4.1.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206814","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T18:37:13Z","timestamp":1541529433000},"page":"e0206814","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5719-8423","authenticated-orcid":true,"given":"Geoffrey","family":"Urbanski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Caillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Kauffenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Antoine","family":"Begorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Loufrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Henrion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Belizna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"S Miyakis","year":"2006","journal-title":"J Thromb Haemost JTH"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.87.11.4120","article-title":"Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)","volume":"87","author":"HP McNeil","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/intimm\/3.12.1217","article-title":"Molecular definition of human beta 2-glycoprotein I (beta 2-GPI) by cDNA cloning and inter-species differences of beta 2-GPI in alternation of anticardiolipin binding","volume":"3","author":"E Matsuura","year":"1991","journal-title":"Int Immunol"},{"key":"ref4","first-page":"5732","article-title":"The anti-beta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species\u2019 evolution","volume":"157","author":"A Tincani","year":"1996","journal-title":"J Immunol Baltim Md"},{"issue":"Suppl 1","key":"ref5","first-page":"22","article-title":"Do some antiphospholipid antibodies target endothelial cells?","volume":"147","author":"M Dueymes","year":"1996","journal-title":"Ann Med Interne (Paris)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0032-1311827","article-title":"Pathogenesis of the antiphospholipid syndrome","volume":"38","author":"R Willis","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.CIR.97.9.900","article-title":"Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome","volume":"97","author":"J George","year":"1998","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0028-1082267","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms","volume":"34","author":"SS Pierangeli","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.semarthrit.2007.08.002","article-title":"Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding","volume":"37","author":"CC Belizna","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"ref10","first-page":"III12","article-title":"Intact and altered endothelium in regulation of vasomotion","volume":"86","author":"A Lerman","year":"1992","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/01.CIR.99.15.1997","article-title":"Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo","volume":"99","author":"SS Pierangeli","year":"1999","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1172\/JCI39828","article-title":"Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via \u03b22GPI and apoER2","volume":"121","author":"S Ramesh","year":"2011","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0008-6363(99)00134-0","article-title":"Tetrahydrobiopterin and endothelial nitric oxide synthase activity","volume":"43","author":"F Cosentino","year":"1999","journal-title":"Cardiovasc Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/bj3620733","article-title":"The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study","volume":"362","author":"J V\u00e1squez-Vivar","year":"2002","journal-title":"Biochem J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/hrt.2007.122184","article-title":"Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia","volume":"94","author":"F Cosentino","year":"2008","journal-title":"Heart Br Card Soc"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"G Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.autrev.2018.01.016","article-title":"New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis","volume":"17","author":"A Casian","year":"2018","journal-title":"Autoimmun Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/art.24232","article-title":"Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies","volume":"61","author":"MG Tektonidou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/ard.2008.093013","article-title":"Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort","volume":"68","author":"R Kaiser","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/jth.12363","article-title":"Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients","volume":"11","author":"A Schmidt-Tanguy","year":"2013","journal-title":"J Thromb Haemost JTH"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/rheumatology\/kex378","article-title":"The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies","volume":"57","author":"K Schreiber","year":"2018","journal-title":"Rheumatol Oxf Engl"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers","volume":"112","author":"JH Rand","year":"2008","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1161\/01.CIR.96.12.4380","article-title":"Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice","volume":"96","author":"MH Edwards","year":"1997","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1055\/s-0038-1642501","article-title":"Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice","volume":"71","author":"SS Pierangeli","year":"1994","journal-title":"Thromb Haemost"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1055\/s-0038-1649940","article-title":"Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome","volume":"74","author":"SS Pierangeli","year":"1995","journal-title":"Thromb Haemost"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1073\/pnas.93.16.8606","article-title":"A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice","volume":"93","author":"T Olee","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/01.CIR.94.7.1746","article-title":"Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies","volume":"94","author":"SS Pierangeli","year":"1996","journal-title":"Circulation"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1182\/blood-2010-08-300715","article-title":"\u03b2\u2082-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model","volume":"117","author":"A Arad","year":"2011","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5812\/nephropathol.10112","article-title":"The NF-\u03baB specific inhibitor DHMEQ prevents thrombus formation in a mouse model of antiphospholipid syndrome","volume":"2","author":"M Nishimura","year":"2013","journal-title":"J Nephropathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood-2002-05-1310","article-title":"Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster","volume":"101","author":"M Jankowski","year":"2003","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0961203307086931","article-title":"Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?","volume":"17","author":"C Belizna","year":"2008","journal-title":"Lupus"},{"key":"ref32","first-page":"1737","article-title":"Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"7","author":"V Pengo","year":"2009","journal-title":"J Thromb Haemost JTH"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1476-5381.1996.tb15196.x","article-title":"Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats","volume":"117","author":"FJ Dowell","year":"1996","journal-title":"Br J Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fphys.2010.00145","article-title":"Cyclooxygenase-2 inhibition restored endothelium-mediated relaxation in old obese zucker rat mesenteric arteries","volume":"1","author":"E Vessi\u00e8res","year":"2010","journal-title":"Front Physiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s11926-013-0324-4","article-title":"Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis","volume":"15","author":"C. Mineo","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.rdc.2006.05.006","article-title":"Accelerated atheroma in the antiphospholipid syndrome","volume":"32","author":"E Matsuura","year":"2006","journal-title":"Rheum Dis Clin North Am"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780400322","article-title":"Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation","volume":"40","author":"N Del Papa","year":"1997","journal-title":"Arthritis Rheum"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-0037-1614108","article-title":"Systemic endothelial cell markers in primary antiphospholipid syndrome","volume":"84","author":"FM Williams","year":"2000","journal-title":"Thromb Haemost"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaut.2009.07.004","article-title":"Patients with antiphospholipid syndrome display endothelial perturbation","volume":"34","author":"M Cugno","year":"2010","journal-title":"J Autoimmun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/096120339600500523","article-title":"Modulation of endothelial cell function by antiphospholipid antibodies","volume":"5","author":"PL Meroni","year":"1996","journal-title":"Lupus"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"R Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13075-015-0790-3","article-title":"Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus","volume":"17","author":"A Virdis","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3899\/jrheum.100494","article-title":"Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome","volume":"37","author":"PRJ Ames","year":"2010","journal-title":"J Rheumatol"},{"key":"ref44","first-page":"955","article-title":"Plasma tetrahydrobiopterin\/dihydrobiopterin ratio: a possible marker of endothelial dysfunction","volume":"73","author":"M Takeda","year":"2009","journal-title":"Circ J Off J Jpn Circ Soc"},{"key":"ref45","article-title":"Chronic Hydroxychloroquine Improves Endothelial Dysfunction and Protects Kidney in a Mouse Model of Systemic Lupus Erythematosus","author":"M G\u00f3mez-Guzm\u00e1n","year":"2014","journal-title":"Hypertension"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/rheumatology\/keh722","article-title":"Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model","volume":"44","author":"J Delgado Alves","year":"2005","journal-title":"Rheumatol Oxf Engl"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pharmthera.2013.07.004","article-title":"Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?","volume":"140","author":"L Rochette","year":"2013","journal-title":"Pharmacol Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-385061-4.00005-2","article-title":"Regulation of endothelial cell tetrahydrobiopterin pathophysiological and therapeutic implications","volume":"60","author":"DG Harrison","year":"2010","journal-title":"Adv Pharmacol San Diego Calif"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.autrev.2009.02.025","article-title":"Beta2-glycoprotein I and annexin A5 phospholipid interactions: artificial and cell membranes","volume":"9","author":"M Frank","year":"2009","journal-title":"Autoimmun Rev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T12:15:34Z","timestamp":1662380134000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206814"}},"subtitle":[],"editor":[{"given":"Israel","family":"Silman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,6]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206814","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,6]]}}}